ArticleCase reports in surgery2026
Robotic-Assisted Extended Thymus Carcinoma Resection With Unilateral Total Pleurectomy and Hyperthermic Intrathoracic Chemotherapy (HITOC).
Article in Case reports in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Robotic-Assisted Extended Thymus Carcinoma Resection With Unilateral Total Pleurectomy and Hyperthermic Intrathoracic Chemotherapy (HITOC).Case reports in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thymic squamous cell carcinoma (SCC) is an aggressive form of thymic cancer that is often diagnosed at an advanced stage. Hyperthermic intrathoracic chemotherapy (HITOC) is a treatment option for advanced thoracic and especially pleural malignancies, though it is not yet the standard of care. However, the success of treating pleural cancers with HITOC protocols has been well documented in selected cases. Robotic-assisted thoracoscopic surgery (RATS) has become the standard procedure for thymectomy, even for locally advanced tumors. In this report, we describe the treatment of a 53-year-old patient with a locally advanced Masaoka-Koga stage IVa thymic SCC and concomitant limited pleural carcinomatosis who was successfully treated by RATS thymectomy and HITOC. The report highlights the diagnostic challenges, therapeutic approach, and postoperative care, emphasizing the advantages of minimally invasive, robot-assisted surgery even in advanced cases. RATS with HITOC can be a safe and effective method for the treatment of advanced thymic carcinoma. This case report demonstrates that this procedure enables rapid postoperative recovery and can be performed with minimal morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.